Literature DB >> 8936069

The Acne Disability Index: usefulness confirmed.

A M Oakley1.   

Abstract

One hundred and four patients with acne completed a questionnaire derived from the Cardiff Acne Disability Index Questionnaire. In addition, 59% of patients returned an identical follow-up questionnaire 6 months later. Significant disability from acne was identified in many patients, with the median initial Acne Disability Index (ADI) being 6 (maximum possible 15), improving to 3 after treatment. Scores correlated poorly with the clinical severity of acne. The questionnaire proved useful for identifying patients with poor self-image who might benefit from more potent treatment for their acne, and to evaluate the effect of treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8936069     DOI: 10.1111/j.1440-0960.1996.tb00992.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  Severity and impact of acne vulgaris on the quality of life of adolescents in Nigeria.

Authors:  Evelyn E Ogedegbe; Eshan B Henshaw
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-12-08

2.  FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

Authors:  Alexandra Poinas; Marie Lemoigne; Sarah Le Naour; Jean-Michel Nguyen; Solène Schirr-Bonnans; Valery-Pierre Riche; Florence Vrignaud; Laurent Machet; Jean-Paul Claudel; Marie-Thérèse Leccia; Ewa Hainaut; Nathalie Beneton; Cécile Dert; Aurélie Boisrobert; Laurent Flet; Anne Chiffoleau; Stéphane Corvec; Amir Khammari; Brigitte Dréno
Journal:  Trials       Date:  2020-06-25       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.